Recover faster.
Age slower.
Peptide protocols, prescribed. Sermorelin is the first compound in the stack — a GHRH analog studied for sleep, recovery, and body composition after 35. Reviewed by licensed clinicians, compounded by 503A pharmacies.
Requires clinical evaluation · Not available in all states · For men 35–55 · Individual results vary
GHRH analog
Mechanism
503A grade
Pharmacy standard
Free intake
No commitment
The process
Clinical, not concierge.
Faster than you think.
Three steps between you and a Sermorelin protocol prescribed by a licensed clinician and compounded to pharmaceutical grade.
Complete your intake
Answer a focused questionnaire on goals, history, sleep, and labs if you have them. A licensed clinician receives it for review.
Clinician evaluation
An independently licensed provider evaluates your case. If a peptide protocol is appropriate, they prescribe it. If not, they explain why and what is.
Your protocol ships
Your prescription is compounded by a licensed 503A pharmacy and shipped to you. Refills require a fresh prescription each cycle, with clinician check-ins.
All clinical decisions are made by independently licensed healthcare providers
The protocol
Sermorelin first.
The stack expands.
One compound now, prescribed and compounded to pharmaceutical grade. The full peptide stack expands once the FDA's July 2026 PCAC ruling clears additional compounds for legal compounding.
Sermorelin
Available nowThe entry compound. GHRH analog. Telehealth-precedented since the 1990s.
What it is
- →GHRH analog — signals your own pituitary, not synthetic HGH
- →Studied for sleep architecture, recovery markers, and body composition after 35
- →Compounded to verified concentration by licensed 503A pharmacies
- →Currently FDA Category 1 — legal, established, telehealth-precedented
- →Self-administered nightly subcutaneous injection
Stack roadmap
The protocol grows with the regulatory landscape.
Cross-sell upgrade
CJC-1295 + Ipamorelin
Pending favorable PCAC ruling July 2026
Recovery attach
BPC-157
Pending favorable PCAC ruling July 2026
Premium tier
NAD+
Available post-launch, regulatory status stable
Biomarker depth
Lab panel
Add-on for protocol monitoring
Mechanism
What Sermorelin actually does at the cell level.
Pulsatile signaling
Sermorelin is a 29-amino-acid analog of growth hormone-releasing hormone. It triggers your own pituitary to release growth hormone in the natural pulsatile pattern, rather than flooding the system with synthetic HGH.
Sleep architecture
Endogenous GH release peaks during deep (slow-wave) sleep. By supporting the GHRH→GH axis, Sermorelin is studied for its role in restoring sleep-stage distribution disrupted by age or stress.
Recovery + body composition
Published research links the GH/IGF-1 axis to lean mass maintenance, fat oxidation, and post-exercise tissue repair. Sermorelin's mechanism targets the same axis without bypassing the body's own regulatory feedback.
Research disclaimer: The information above describes published mechanisms and does not constitute outcome claims. Compounded medications are not FDA-approved. Sermorelin is an active ingredient with established clinical history; compounded formulations are prepared by a licensed 503A pharmacy per individual prescription and are distinct from commercially manufactured products.
Individual results vary. All prescribing decisions are made by independently licensed healthcare providers. Not available in all states.
The real difference
The internet has
supplements and gray-market gear.
Forma has the prescription.
The DIY route
Supplements + research-chemical peptides
- Underground peptides from research-chemical sites — no purity verification, no medical oversight
- Generic supplement stacks marketed as growth-hormone boosters with no mechanistic basis
- Synthetic HGH from gray-market sources — illegal, expensive, and bypasses your own regulatory feedback
- No labs, no clinician evaluation, no contraindication screening
- No protocol adjustment as you respond — or don't
The Forma protocol
Prescription Sermorelin
- →Sermorelin — a GHRH analog with decades of clinical history, prescribed not gray-market
- →Compounded to verified pharmaceutical grade by licensed 503A pharmacies
- →Independent licensed clinician reviews your goals, history, and contraindications
- →Your protocol is matched to your goals and adjusted at clinician check-ins
- →Path to a wider stack as the FDA clears more compounds for legal compounding
OTC supplements and gray-market peptides are widely available. Prescription Sermorelin compounded by a 503A pharmacy is a different category — clinician- prescribed, monitored, and traceable to a licensed source.
Why it works
Old science.
Real prescription.
Sermorelin isn't trending — it's been studied for forty years. What's new is the access pathway: a real telehealth model with licensed providers and pharmaceutical-grade compounding.
Established science
Sermorelin's mechanism — pulsatile GHRH signaling — has been studied since the 1980s. PubMed indexes peer-reviewed literature on the GHRH/GH/IGF-1 axis going back four decades.
Search PubMed →Independently licensed clinicians
Every protocol is reviewed by a healthcare provider licensed in your state. They make all prescribing decisions independently. Forma is a marketing partner — clinical authority sits with the provider.
503A compounding standard
Prescriptions are compounded by licensed 503A pharmacies operating under USP standards, with a fresh patient-specific prescription required every cycle. Not a manufactured supplement.
FAQ
Questions men 35–55 actually ask,
answered straight.
Get evaluated
See if a protocol
is right for you.
Short intake. A licensed clinician reviews whether a Sermorelin protocol is appropriate within 1–2 business days. The intake and consult are free — $1 reservation holds your slot and is fully refunded.